锐客网

  1. 首页 > 生活杂烩 > 健康 > >

肾病|病因层面治疗 IgA 肾病？靶向治疗了解一下！( 三 )


2. Meguid ENA, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005; 365:331-40.
3. Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012; 379:815-22.
4. Barratt J, Rovin BH, Cattran D, et al. Why target the gut to treat IgA Nephropathy? Kidney Int Rep. 2020, published online.
5. Zhang YM, Zhou XJ, Zhang H. What Genetics Tells Us About the Pathogenesis of IgA Nephropathy: The Role of Immune Factors and Infection. Kidney Int Rep. 2017;2:318-31.
【肾病|病因层面治疗 IgA 肾病？靶向治疗了解一下！】6. Yeo SC, Cheung CK, Barratt J. New insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol. 2018;33:763-77.
7. Floege J. Fatal Attraction: Immunoglobulin A and the Glomerular Mesangium. J Am Soc Nephrol. J Am Soc Nephrol. 2019;30:1139-41.
8. Yasutake J, Suzuki Y, Suzuki H, et al. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant. 2015;30:1315-21.
9. Moldoveanu Z, Wyatt RJ, Lee JY, et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int. 2007;71:1148-54.
10. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 2005; 68: 167-72.
11. Zhao N, Hou P, Lv JC, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression. Kidney Int. 2012;82:790-6.
12. Matousovic K, Novak J, Yanagihara T, et al. IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol Dial Transplant. 2006; 21: 2478-84.
13. Allen AC, Bailey EM, Brenchley PE, et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int. 2001; 60: 969-73.
14. Inoue T, Sugiyama H, Hiki Y, et al. Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy. Clin Immunol. 2010; 136: 447-55.
15. Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;25(368):2402-14.
16. Kerr MA. The structure and function of human IgA. Biochem J. 1990; 271: 285-296.
17. Tarelli E, Smith AC, Hendry BM, et al. Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionization time-of-flight mass spectrometry. Carbohydr Res. 2004; 339: 2329-35.
18. Gomes MM, Suzuki H, Brooks MT, et al. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study. Biochemistry. 2010; 49: 5671-82.
19. Boyd JK, Cheung CK, Molyneux K, et al. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012;81:833.
20. Barratt J, Feehally J. Primary IgA nephropathy: new insights into pathogenesis. Semin Nephrol. 2011;31:349.
21. Zhang YM, Zhang H. Insights into the Role of Mucosal Immunity in IgA Nephropathy. Clin J Am Soc Nephrol. 2018;13:1584-6.
22. Watts P, Smith A. TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tract. Expert Opin Drug Deliv. 2005;2:159–67.
23. Edsb?cker S, Wollmer P, Nilsson ?, et al. Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules. Gastroenterology. 1993;104:A695.
24. Smith AC, Molyneux K, Feehally J, et al. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol. 2006;17:3520–8.
25. Fellstrom BC, Barratt J, Cook H, et al. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet. 2017;389:2117–127.
26. Lv JC, Zhang H, Wong MG, et al. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. JAMA. 2017;318(5):432-42.

推荐阅读


上一篇：荨麻疹|荨麻疹很难“断根”？不妨先了解这4个诱因，或能事半功倍

下一篇：原发性高血压|我为什么会得高血压？与这2件事有关，你却天天都在犯！